Foundation Fighting Blindness

Funding Profiles

Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner)

The mission of the foundation is to accelerate the translation of laboratory based research into clinical trials for treatments and cures of retinal degenerative diseases.

The goal of the foundation is to develop a bridge between scientific, clinical, governmental, pharmaceutical and financial communities to advance clinical trials of candidate pharmaceutical and genetic therapies and delivery systems for orphan retinal degenerative diseases (RDD’s). In this regard, the foundation wishes to educate the scientific and clinical communities of opportunities and processes of drug discovery.

As a medical research institute, the foundation will search for candidate therapies and explore new pathogenetic pathways of retinal diseases to further the drug discovery process.

The foundation will raise funds to support Phase I and Phase II clinical trials in order to expedite the commercialization of candidate therapies for RDD patients. The foundation will also provide assistance to the management of clinical trials and subsequent commercialization.

Contact information:

Administrative Office
11435 Cronhill Drive
Owings Mills, MD 21117
Ph: (410) 568-0150
Fax: (410) 363-2393
TDD: (410) 363-7139

Steve Rose, Ph.D.
srose@blindness.org

The fund is not a competitive fund
web site: http://www.nnri.info/index.htm